Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia

MS Steiner, CR Pound - Clinical prostate cancer, 2003 - Elsevier
Men with high-grade prostatic intraepithelial neoplasia (PIN) evident on prostate biopsy are
at high risk for the eventual development of prostate cancer. The ability to reverse high …

Epidemiology of high-grade prostatic intraepithelial neoplasia

A Wael Sakr, A Billis, P Ekman, T Wilt… - … Journal of Urology …, 2000 - Taylor & Francis
This review summarizes published data dealing with the prevalence of high-grade prostatic
intraepithelial neoplasia (HGPIN) in a variety of prostate tissue samples. Additionally, we …

Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cells

L Montalvo, MJ Carmena, O Bolanos… - Bioscience …, 2004 - Springer
Flutamide is a nonsteroidal antiandrogen that is frequently used for total androgen blockage
in the treatment of advanced prostate cancer. We investigated the effect of this antiandrogen …

Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism

Y Wang, C Shao, CH Shi, L Zhang… - Asian journal of …, 2005 - Wiley Online Library
Aim: To explore the effect of androgen receptor (AR) on the expression of the cell cycle‐
related genes, such as CDKN1A and BTG1, in prostate cancer cell line LNCaP. Methods …

Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia

G Godoy, SS Taneja - Prostate Cancer and Prostatic Diseases, 2008 - nature.com
High-grade prostatic intraepithelial neoplasia (HGPIN) is a premalignant lesion associated
with increased risk of coexistent cancer or delayed progression to carcinoma. Extended …

523: Risk of Prostate Cancer on Re-Biopsy Following a Diagnosis of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) is Related to the Number of Cores …

M Herawi, C Cavallo, H Kahane… - The Journal of Urology, 2005 - auajournals.org
RESULTS: An immotile cell line, SO-RY, was successfully established, and it has been
maintained over 100 passages. The doubling time of SO-RY was 96 hours. Chromosomal …

Persistence of prostatic intraepithelial neoplasia after effective chemoprevention of microscopic prostate cancer with antiandrogen in a rat model

A Yamauchi, K Kawai, S Tsukamoto, Y Ideyama… - The Journal of …, 2006 - Elsevier
PURPOSE: We determined the chemopreventive effect of the antiandrogen bicalutamide
(Zeneca Co., Ltd., Osaka, Japan) on Fisher 344 rat prostate carcinogenesis induced by …

Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of “hormone-refractory” prostate cancer

O Sartor, M Cooper, M Weinberger… - JNCI: Journal of the …, 1994 - academic.oup.com
Backgroound The best treatment for patients with “hormone-refractory” metastatic prostate
cancer is unclear, particularly in patients for whom suramin and hydrocortisone have failed …

[PDF][PDF] Multifocal high-grade prostatic intraepithelial neoplasia is still a significant risk factor for adenocarcinoma

JR Srigley, JL Merrimen, G Jones, M Jamal - … Urological Association Journal, 2010 - cuaj.ca
We read with great interest the recent CUA guidelines on prostate biopsy methodology. 1
We note that the recommendation regarding high-grade prostatic intra-epithelial neoplasia …

Is high‐grade prostatic intraepithelial neoplasia (HGPIN) a reliable precursor for prostate carcinoma? Implications for clonal evolution and early detection strategies

Y Tolkach, G Kristiansen - The Journal of pathology, 2018 - Wiley Online Library
High‐grade prostatic intraepithelial neoplasia (HGPIN) is a documented putative precursor
lesion for invasive prostate adenocarcinoma. However, the precise mechanisms of the …